A preliminary trial for the efficacy of TZT in the management of T2DM showed that this drug was less effective compared to semaglutide (an analogue of GLP-1) in the reduction of insulin resistance (IR) and glycated hemoglobin (HbA 1c ) (Fras et al
doi: 10.1007/s11064-015-1600-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 58.Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, et al
Data availability The authors declare that the data supporting the findings of this study are available within the Article, Source Data, and its Supplementary Information
Our digital solution enhances chronic condition management, reduces reliance on costly medications, and helps health plans lower GLP-1 spend, maximize the value of your AOM spend, and drive more effective obesity management outcomes, supporting broader healthcare cost reduction programs
All hair follicles came from the back of the scalp the area least affected by androgenetic alopecia